title: Appropriateness of anemia management in hemodialysis patients.
abstract: The anemia of end stage renal disease (ESRD) is common and often severe complication that can be managed successfully by erythropoiesis-stimulating agents (ESA) administration.
  
  
  OBJECTIVE
  To investigate current practice of anemia management in hemodialysis patients and to assess the appropriateness of anemia management by comparing observed practice to the Kidney Disease Outcomes Quality Initiative (KDOQI) guideline recommendations.
  
  
  METHODS
  The study was conducted at two hemodialysis centers in Riyadh, Saudi Arabia. Data on anemia parameters, comorbidities, ESA dosing and iron supplementation were collected. The data were collected for 7 months retrospectively from April to the end of May 2008 and prospectively from June to October 2008. Patients who were over 18 years of age with ESRD undergoing hemodialysis were included. Patients were excluded if they have cancer or receiving chemotherapy or radiotherapy.
  
  
  RESULTS
  Data were collected from 87 patients. Mean Hgb value for those patients was 11.16 ± 0.97 g/dL. Thirty-nine patients (45%) had mean Hgb values between 11.0 and 12.0 g/dL the target range recommended by KDOQI guideline. The mean weekly prescribed dose of erythropoietin was 8099 ± 5946 IU/Week (135 ± 99 IU/kg/Week). Information on ferritin concentrations was available for 48 (55%) patients. The mean serum ferritin concentration for those patients was 693 ± 420.5 ng/mL. Fifty-two patients had transferrin saturation (TSAT) values recorded. The mean TSAT value was 38.5 ± 19.7%.
  
  
  CONCLUSIONS
  There is an opportunity to improve anemia management in hemodialysis patients particularly thorough evaluation of causes of inadequate response rate and better monitoring and management of iron status.
authors: Department of Clinical Pharmacy, King Saud University, Saudi Arabia.
authors: Nahla A
authors: NA
authors: Al-Ageel
authors: Sinaa A
authors: SA
authors: Al-Aqeel
authors: Norah O
authors: NO
authors: Abanmy
authors: Jamal S
authors: JS
authors: Alwakeel
authors: Alaa
authors: A
authors: Sabry
authors: Khalid A
authors: KA
authors: Alsaran
keywords: Anemia; Chronic kidney disease; Dialysis; Erythropoietin; Iron status
references: Saudi J Kidney Dis Transpl. 2007 Jun;18(2):206-14
references: 17496396
references: Nephrol Dial Transplant. 2005 May;20 Suppl 3:iii3-24
references: 15824128
references: N Engl J Med. 2006 Nov 16;355(20):2085-98
references: 17108343
references: Curr Opin Nephrol Hypertens. 2010 Mar;19(2):153-9
references: 20051850
references: Nephrol Dial Transplant. 2011 Apr;26(4):1120-2
references: 21362736
references: Am J Kidney Dis. 2007 Feb;49(2):194-207
references: 17261422
references: N Engl J Med. 2009 Nov 19;361(21):2019-32
references: 19880844
references: Arch Intern Med. 2009 Jun 22;169(12):1104-12
references: 19546410
references: Am J Kidney Dis. 2005 Sep;46(3):481-8
references: 16129210
references: Nephrol Dial Transplant. 2007 Mar;22(3):794-800
references: 17210593
references: Am J Health Syst Pharm. 2007 Jul 1;64(13 Suppl 8):S3-7; quiz S23-5
references: 17591994
references: Am J Health Syst Pharm. 2002 Mar 1;59(5):429-35
references: 11887409
references: Nephrol Dial Transplant. 2004 Jan;19(1):121-32
references: 14671047
references: Expert Opin Pharmacother. 2010 Mar;11(4):597-613
references: 20163271
references: Curr Med Res Opin. 2006 Oct;22(10):1929-37
references: 17022852
references: Am J Kidney Dis. 2009 May;53(5):823-34
references: 19339087
references: Lancet. 2007 Feb 3;369(9559):381-8
references: 17276778
references: Saudi J Kidney Dis Transpl. 2007 Mar;18(1):65-72
references: 17237894
references: Kidney Int. 2009 Jan;75(1):15-24
references: 18813284
references: Kidney Int Suppl. 2006 May;(101):S4-8
references: 16830699
references: Saudi J Kidney Dis Transpl. 2010 Jul;21(4):789-97, 807-16
references: 20731075
references: Kidney Int. 2003 Jul;64(1):295-304
references: 12787422
references: Am J Kidney Dis. 2007 Sep;50(3):471-530
references: 17720528
references: N Engl J Med. 2006 Nov 16;355(20):2071-84
references: 17108342